Search
for
Sort by
Research 571–600 of 1000+
- Identification of Androgen-Inducible TGF-β1 Derived from Dermal Papilla Cells as a Key Mediator in Androgenetic Alopecia
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- Androgenetic Alopecia: Identification of Four Genetic Risk Loci and Evidence for the Contribution of WNT Signaling to Its Etiology
- Androgenetic alopecia in children: report of 20 cases
- Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?
- An Open, Randomized, Comparative Study of Oral Finasteride and 5% Topical Minoxidil in Male Androgenetic Alopecia
- Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil
- Platelet-Rich Plasma and Micrografts Enriched with Autologous Human Follicle Mesenchymal Stem Cells Improve Hair Re-Growth in Androgenetic Alopecia. Biomolecular Pathway Analysis and Clinical Evaluation
- Association of androgenetic alopecia with metabolic syndrome in men: a community-based survey
- Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy
- A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-<i>α</i>-Reductase in the Treatment of Androgenetic Alopecia
- Safety and efficacy of topical minoxidil in the management of androgenetic alopecia
- The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride
- Prevalence and types of androgenetic alopecia in Shanghai, China: a community-based study
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results
- Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy
- A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-<i>α</i>-Reductase in the Treatment of Androgenetic Alopecia
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
- Platelet-rich plasma for androgenetic alopecia: Does it work? Evidence from meta analysis
- Frontal fibrosing alopecia developing after hair transplantation for androgenetic alopecia
- Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial
- A Mechanistic Model of Platelet-Rich Plasma Treatment for Androgenetic Alopecia
- Baldness and the androgen receptor: the AR polyglycine repeat polymorphism does not confer susceptibility to androgenetic alopecia
- USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMEN
- Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia
- Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women
- Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study